H, Z., LEL, H., J, B., L, B., I, C., L, D., . . . D, D. R. (2024). Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial. Clinical lung cancer, 25(7), 653. https://doi.org/10.1016/j.cllc.2024.08.008
Chicago Style (17th ed.) CitationH, Zeng, et al. "Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial." Clinical Lung Cancer 25, no. 7 (2024): 653. https://doi.org/10.1016/j.cllc.2024.08.008.
MLA (9th ed.) CitationH, Zeng, et al. "Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial." Clinical Lung Cancer, vol. 25, no. 7, 2024, p. 653, https://doi.org/10.1016/j.cllc.2024.08.008.